Brazil Senate Delays E-cigarette Legislation Vote by 30 Days

Jun.12.2024
Brazil Senate Delays E-cigarette Legislation Vote by 30 Days
Brazilian Senate delays e-cigarette bill discussion for 30 days, considering amendments to prevent underage sales and taxation concerns.

According to SBT News on June 11, the Senate Economic Affairs Committee in Brazil (Comissão de Assuntos Econômicos, CAE) has once again postponed the discussion of a bill (PL) regarding the production, sale, inspection, and advertising of e-cigarettes for 30 days. The discussion, originally scheduled for today (June 11), was delayed at the request of Senator Damares Alves from the Brazilian Republican Party, which was approved by the committee.


Before the vote on the bill, the bill's rapporteur Eduardo Gomes stated that he had to perfect the vote because Senator Mecias de Jesus had proposed two amendments to the bill. However, Gomes opposed these two amendments and maintained his support for Soraya Thronicke, only accepting one amendment.


The reporter revised Article 24 of the law, which states that manufacturers, importers, traders, or any individual shall not provide or sell e-cigarettes to individuals under the age of 18, nor shall they offer or propose to provide products to those under 18, whether for free or for a fee, directly or indirectly. Anyone who violates the above provisions will face a fine of no less than twenty thousand reals (3727 US dollars) and no more than ten million reals (1.86 million US dollars). In addition to the fine, intentionally violating the rules will also constitute a crime under Article 243 of the Children and Adolescents Law, and the prescribed penalties (2 to 4 years of imprisonment and fine, if the facts do not constitute a more serious crime) shall be doubled.


Another amendment proposed by the Mesiases is to tax e-cigarettes, a proposal that has raised concerns from proponent Solaya.


Imposing equal taxes on these products may encourage the black market, damage public health, and undermine tobacco control policies.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Joint law enforcement in Paraná, Brazil, seized approximately $130,000 worth of smuggled e-cigarettes hidden in an abandoned truck
Joint law enforcement in Paraná, Brazil, seized approximately $130,000 worth of smuggled e-cigarettes hidden in an abandoned truck
Joint law enforcement officers in Paraná, Brazil, seized a batch of smuggled e-cigarettes worth approximately 700,000 reais (about 130,000 US dollars). The goods were hidden in a vehicle that was abandoned during a police chase.
Sep.29 by 2FIRSTS.ai
Company | JTI Executive: The company has invested over 300 million euros in Romania and created 1,500 jobs
Company | JTI Executive: The company has invested over 300 million euros in Romania and created 1,500 jobs
JTI has operated in Romania for over 30 years, investing over €300M and creating 1,500 jobs. It paid €1.3B in taxes in 2024. Executive Lucine Ovumyan recently told Antena 3 that the company contributes significantly to the economy but is concerned about a proposed EU tobacco tax directive. She said it could lead to a 59% tax increase over three years and fuel illegal trade. She called for balanced tax policies and dialogue to support growth, innovation, and fair competition.
Sep.02 by 2FIRSTS.ai
Bangladesh Roundtable Focuses on Tobacco Control: Experts Call for Accelerated Passage of Tobacco Control Law Without Industry Interference
Bangladesh Roundtable Focuses on Tobacco Control: Experts Call for Accelerated Passage of Tobacco Control Law Without Industry Interference
Tobacco blocks Bangladesh's SDGs, esp 2030: cut premature NCD deaths by 1/3. 71% deaths from NCDs, tobacco main cause. PROGGA-Anti-Tobacco experts want strong, industry-free laws, strict enforcement, faster Smoking/Tobacco (Control) Bill revision, resist tobacco firms.
Sep.22 by 2FIRSTS.ai
Sneak Peek | Vabeen Unveils Full Line of New Products at InterTabac 2025, Focusing on Upgraded Experience and Technological Innovation
Sneak Peek | Vabeen Unveils Full Line of New Products at InterTabac 2025, Focusing on Upgraded Experience and Technological Innovation
Vabeen will unveil its complete product line—disposable, pod, and open-system devices—at booth 6.A24 at InterTabac 2025. The showcase highlights the brand's latest innovations in high capacity, multi-flavor, and smart devices, demonstrating its strategic focus and strength in the global market.
Sep.17
UK Southeast Sees Surge in Seizures of Illegal Vapes – Single Largest Haul Nears 1,250 Units
UK Southeast Sees Surge in Seizures of Illegal Vapes – Single Largest Haul Nears 1,250 Units
Local authorities in Southeast England have reported a sharp rise in the number of illegal e-cigarettes seized. In 2024, Sussex confiscated around 21,200 units, while Surrey saw its tally rise from about 500 in 2020 to nearly 14,140—a 28-fold increase. The government pledged to support councils in tackling the issue, while industry groups urged harsher economic penalties for rogue traders and more funding for enforcement, warning that the disposable vape ban could fuel the black market.
Aug.18